Related Experiment Video
Updated: Aug 24, 2026

Using Click Chemistry to Measure the Effect of Viral Infection on Host-Cell RNA Synthesis
Published on: August 9, 2013
Methylene blue photoinactivation of RNA viruses
Robert A Floyd1, J Edward Schneider, Dirk P Dittmer
1Oklahoma Medical Research Foundation, Auburn University, Auburn, AL 36849, USA. robert-floyd@omrf.ouhsc.edu
Abstract:
We present a review of the current status of the use of methylene blue (MB) photoinactivation of viruses starting with the first early observations up to its current use to inactivate HIV-1 in blood products. Basic mechanism of action studies conducted with model bacteriophages indicate that MB-photomediated viral RNA-protein crosslinkage is a primary lesion and that oxygen, specifically singlet oxygen, is very important also. Basic studies on the mechanism of action with HIV are lacking; however, we do show new data illustrating that viral reverse transcriptase inactivation per se cannot account for MB-mediated photoinactivation. We also show data illustrating that MB photomediates the inactivation of West Nile Virus, a flavivirus, which poses a significant new threat to the continental US. MB photoinactivation of viruses show significant promise because the technology not only offers significant potency but the history of safe MB use in human therapy makes it attractive also.
Insights
Methylene blue (MB) photoinactivation effectively inactivates viruses like HIV-1 and West Nile Virus by damaging viral RNA and proteins. This promising technology leverages MB's safe history in human therapy for potential blood product safety.
Area of Science:
- Virology
- Photochemistry
- Biotechnology
Background:
- Methylene blue (MB) is used for virus photoinactivation, particularly for HIV-1 in blood products.
- Early studies with bacteriophages suggest MB photoinactivation involves RNA-protein crosslinking, with singlet oxygen playing a key role.
Purpose of the Study:
- To review the current status of MB photoinactivation for viruses.
- To investigate the mechanism of MB photoinactivation against HIV-1 and West Nile Virus (WNV).
Main Methods:
- Review of existing literature on MB photoinactivation.
- Experimental data on HIV-1 and WNV inactivation using MB and light.
Main Results:
- MB photoinactivation is effective against HIV-1 and West Nile Virus.
- Viral reverse transcriptase inactivation alone does not explain MB-mediated photoinactivation.
- Singlet oxygen is crucial for MB-mediated viral inactivation.
Conclusions:
- MB photoinactivation shows significant promise for broad-spectrum viral inactivation.
- The established safety profile of MB in human therapy enhances its attractiveness for clinical applications.
- Further research into the mechanism of action against HIV-1 is needed.
Related Concept Videos
Inhibitors Of Virion Release
Viruses with RNA Genomes
RNA Interference
This process occurs naturally in cells, often through the activity of genomically-encoded microRNAs. Researchers can take advantage of this mechanism by introducing synthetic RNAs to deactivate specific genes for research or therapeutic purposes. For example, RNAi could be used...
Inhibitors of Viral Protein Synthesis
Experimental RNAi
Types of RNA
RNA Performs Diverse...

